Summary
This prediction ended on 10.05.17 with a price of €12.18. With a performance of 72.21% the BUY prediction by Steppenwolf0815 was a big success. Steppenwolf0815 has 50% into this predictionEvotec is a German-based biotech company that provides drug discovery and development solutions to pharmaceutical and biotechnology companies. The company operates in the fields of neuroscience, immunology, oncology, and infectious diseases, and its services include hit identification, target validation, and preclinical and clinical development. Evotec has partnerships with major pharmaceutical companies and has developed its own pipeline of drugs, with a focus on developing treatments for conditions such as Alzheimer's disease and diabetes. The company is listed on the Frankfurt and NASDAQ stock exchanges and has a market capitalization of approximately €5.5 billion.
Performance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Evotec SE | -1.600% | -1.600% | -62.154% | -75.372% |
iShares Core DAX® | -0.621% | 1.080% | 11.291% | 16.439% |
iShares Nasdaq 100 | -4.503% | -5.432% | 22.172% | 39.304% |
iShares Nikkei 225® | -2.562% | -1.617% | 7.262% | 8.383% |
iShares S&P 500 | -1.706% | -1.223% | 22.550% | 40.997% |
Comments by Steppenwolf0815 for this prediction
In the thread Evotec AG diskutieren
Kooperation mit Celgene
Die Kooperation mit Celgene sollte sich hier positiv auswirken. Langfristig sehe ich hier noch viel höhere Kurse. Denke das ist ein Wert der über viele Jahre Freude macht.